Adam Schlichtmann > Ropes & Gray LLP > Boston, United States > Lawyer Profile
Ropes & Gray LLP Offices
![Ropes & Gray LLP company logo](https://www.legal500.com/wp-content/uploads/sites/13/2022/05/50844.jpg?v=1653306080)
800 BOYLSTON STREET
BOSTON, MA 02199
MASSACHUSETTS
United States
- Firm Profile
- Go to...
Adam Schlichtmann
![Adam Schlichtmann photo](https://www.legal500.com/wp-content/uploads/sites/13/2023/07/53559_1216542.jpg)
Work Department
Adam is a partner in the asset management group. Adam focuses on representing registered investment companies, both open- and closed-end funds, and investment advisers in regulatory, transactional and compliance matters. On a regular basis, he provides advice regarding the creation, registration and operation of new and existing investment products designed for institutional or retail investors. He also works with clients to respond to new SEC rules affecting the investment management industry.
Prior to attending law school, Adam pursued graduate studies in the Chemistry Department at MIT where he focused on biological chemistry. His research focused on cancer-related mechanisms of DNA damage and repair and platinum-based anti-tumor therapeutics.
Adam was also a consultant for a global professional services firm where he assisted with the merger of two major U.S. pharmaceutical companies.
Top Tier Firm Rankings
- Investment fund formation and management > Alternative/hedge funds
- Finance > Financial services regulation
- Dispute resolution > E-discovery
- Dispute resolution > M&A litigation: defense
- Dispute resolution > Securities litigation: defense
- Healthcare > Life sciences
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Securities litigation: defense
- Healthcare > Service providers
Firm Rankings
- Finance > Capital markets: high-yield debt offerings
- Finance > Capital markets: equity offerings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Tax > Not-for-profit (Fortune 1000 private foundations, national trade associations, and charities)
- Intellectual property > Patents: licensing
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Investment fund formation and management > Private equity funds (including venture capital)
- Tax > US taxes: non-contentious
- Antitrust > Cartel
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: litigation (International Trade Commission)
- Real estate > Real estate
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Securities litigation: defense
- Government > State attorneys general
- Labor and employment > Workplace and employment counseling
- Finance > Capital markets: high-yield debt offerings
- Finance > Fintech
- Antitrust > Merger control
- Intellectual property > Patents: litigation (full coverage)
- Finance > Structured finance: derivatives and structured products
- Media, technology and telecoms > Technology transactions
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Antitrust > Civil litigation/class actions: defense
- M&A/corporate and commercial > Venture capital and emerging companies
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Capital markets: debt offerings
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- International trade > Customs, export controls and economic sanctions
- Finance > Structured finance: securitization
- M&A/corporate and commercial > Shareholder activism